Method for the treatment of chronic myelogenous leukemia

Details Method for the treatment of chronic myelogenous leukemia Method for the treatment of chronic myelogenous leukemia

1986-11-18

1989-07-25

Hazel, Blondel

Drug, bio-affecting and body treating compositions

Lymphokine

Interferon

424 851, 424 856, 424 857, A61K 4502

Patent

active

048512192

ABSTRACT:
Gamma interferon is employed in the treatment of chronic myelogenous leukemia. Patients treated in the benign stage exhibit partial and, in some cases, complete responses to gamma interferon. Successful results have also been obtained with some patients in the blast stage of the disease as well as patients who had been found to be refractory to treatment with alpha interferon.

REFERENCES:
patent: 4743445 (1988-05-01), Delwiche et al.
Chemical Abstracts, vol. 103, Abstract No. 140073w, 1985.
De Clereq et al., Cancer Letters, vol. 15, pp. 223-228, 1982.

Affiliated with

Also associated with

Rating

Method for the treatment of chronic myelogenous leukemia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for the treatment of chronic myelogenous leukemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of chronic myelogenous leukemia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2356997